Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06242249
What this trial is testing

Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma, Refractory
Shahid Beheshti University of Medical Sciences 10
Early research (Phase 1)Study completedNCT01330173
What this trial is testing

Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
National Cancer Institute (NCI) 50
Not applicableStudy completedNCT06012383
What this trial is testing

Alvocade® (Bortezomib) Safety and Effectiveness Study

Who this might be right for
Multiple Myeloma, Refractory
NanoAlvand 57
Early research (Phase 1)Looking for participantsNCT05759793
What this trial is testing

CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Relapsed/Refractory Multiple MyelomaPlasma Cell Leukemia
Nanjing IASO Biotechnology Co., Ltd. 12
Early research (Phase 1)Study completedNCT00004904
What this trial is testing

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Northwestern University
Early research (Phase 1)Not Yet RecruitingNCT07537049
What this trial is testing

BR101 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 10
Testing effectiveness (Phase 2)Looking for participantsNCT04935684
What this trial is testing

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative Syndrome+4 more
University Hospital, Clermont-Ferrand 150
Not applicableStudy completedNCT06151717
What this trial is testing

A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Mayo Clinic 50
Not applicableUnknownNCT01314625
What this trial is testing

A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Early research (Phase 1)Study completedNCT00963820
What this trial is testing

Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07009899
What this trial is testing

BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)

Who this might be right for
Multiple Myeloma
Medical College of Wisconsin 34
Very early researchUnknownNCT04186052
What this trial is testing

Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT02328014
What this trial is testing

Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies

Who this might be right for
Non-Hodgkins LymphomaMultiple MyelomaB-All
Acerta Pharma BV 40
Testing effectiveness (Phase 2)Study completedNCT00445484
What this trial is testing

Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Testing effectiveness (Phase 2)Study completedNCT00790647
What this trial is testing

Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Boston Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07096778
What this trial is testing

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma in Relapse
CellCentric Ltd. 100
Not applicableStudy completedNCT00440635
What this trial is testing

Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 641
Early research (Phase 1)Looking for participantsNCT07239323
What this trial is testing

In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies

Who this might be right for
B-Acute Lymphoblastic LeukemiaB Cell Non-Hodgkin's LymphomaMultiple Myeloma
Chongqing Precision Biotech Co., Ltd 24
Not applicableLooking for participantsNCT00898235
What this trial is testing

Collection of Samples and Clinical Data From Patients With Amyloid Diseases

Who this might be right for
Multiple Myeloma
Boston Medical Center 10,000
Early research (Phase 1)Ended earlyNCT03710915
What this trial is testing

HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed and Refractory Multiple Myeloma
HitGen Inc. 3
Next Page